Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-31

Clinical Trial Update: Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ophthalmic solution PRO-087 to Systane Ultra products for dry eye, with completed results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRO-087 (null)
  • Systane Ultra
  • Systane Ultra Preservative Free

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2019-10-31